Loading
Latest filing published 31 Jan 2023 for Meridian Bioscience INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Catherine Sazdanoff is a declared insider of Meridian Bioscience Inc (board member), with filings sourced from SEC (Form 4). Over a trading history stretching from 26 January 2022 to 31 January 2023, the count stands at 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 31 January 2023: a transaction, in Meridian Bioscience Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations